Women, Birth Control Pills, and Thrombophilia: An Analysis of Current Risk Communication

In order to reduce thrombosis, awareness of these conditions can be increased by pharmaceutical manufacturers taking a greater responsibility for producing easily understandable risk information. Also, health care providers and patients must communicate more effectively. At a minimum, testing should be offered to women, if not required, before prescribing birth control pills.

Following the “Quick Facts” box is an introductory paragraph and a “Highlights”
section with bullet points that link to each different section of the webpage. Each
of the following sections are formatted as question and answers. Under the “How
 ...